BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2577020)

  • 1. [Loxoscelism in Chile. Epidemiologic, clinical and experimental studies].
    Schenone H; Saavedra T; Rojas A; Villarroel F
    Rev Inst Med Trop Sao Paulo; 1989; 31(6):403-15. PubMed ID: 2577020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic pictures produced spiders bites in Chile: latrodectism and loxoscelism].
    Schenone H
    Rev Med Chil; 2003 Apr; 131(4):437-44. PubMed ID: 12870240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous loxoscelism with edematous predominance].
    Schenone H
    Bol Chil Parasitol; 1998; 53(3-4):78-83. PubMed ID: 10413884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence and epidemiology of Loxosceles laeta bite. Analysis of consultations to a poison control center].
    Ríos JC; Pérez M; Sánchez P; Bettini M; Mieres JJ; Paris E
    Rev Med Chil; 2007 Sep; 135(9):1160-5. PubMed ID: 18064371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Loxoscelism in children. Analysis of 15 cases].
    Gutiérrez Puelma J; Sagua Franco H
    Rev Chil Pediatr; 1979; 50(4):21-7. PubMed ID: 44558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cutaneous loxoscelism mainly edematous: a case report].
    la Barra Pd; Vial V; Labraña Y; Álvarez AM; Seguel H
    Rev Chilena Infectol; 2015 Aug; 32(4):467-71. PubMed ID: 26436796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe loxoscelism with lethal outcome. Report of one case].
    Zambrano A; González J; Callejas G
    Rev Med Chil; 2005 Feb; 133(2):219-23. PubMed ID: 15824833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loxoscelism and necrotic arachnidism.
    Wasserman GS; Anderson PC
    J Toxicol Clin Toxicol; 1983-1984; 21(4-5):451-72. PubMed ID: 6381752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in visceral cutaneous and cutaneous loxoscelism of hospital management: clinical, evolution and therapeutic proposal].
    Puerto CD; Saldías-Fuentes C; Curi M; Downey C; Andino-Navarrete R
    Rev Chilena Infectol; 2018; 35(3):266-275. PubMed ID: 30534906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil.
    Sezerino UM; Zannin M; Coelho LK; Gonçalves Júnior J; Grando M; Mattosinho SG; Cardoso JL; von Eickstedt VR; França FO; Barbaro KC; Fan HW
    Trans R Soc Trop Med Hyg; 1998; 92(5):546-8. PubMed ID: 9861376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niche modelling of the Chilean recluse spider Loxosceles laeta and araneophagic spitting spider Scytodes globula and risk for loxoscelism in Chile.
    Canals M; Taucare-Rios A; Brescovit AD; Peña-Gomez F; Bizama G; Canals A; Moreno L; Bustamante R
    Med Vet Entomol; 2016 Dec; 30(4):383-391. PubMed ID: 27424870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and epidemiological features of definitive and presumed loxoscelism in São Paulo, Brazil.
    Málaque CM; Castro-Valencia JE; Cardoso JL; Françca FO; Barbaro KC; Fan HW
    Rev Inst Med Trop Sao Paulo; 2002; 44(3):139-43. PubMed ID: 12163906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
    Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
    Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loxoscelism. Experience in 200 patients].
    Droppelmann K; Majluf-Cáceres P; Sabatini-Ugarte N; Valle E; Herrera H; Acuña D
    Rev Med Chil; 2021 May; 149(5):682-688. PubMed ID: 34751320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loxoscelism of the eyelids.
    Edwards JJ; Anderson RL; Wood JR
    Arch Ophthalmol; 1980 Nov; 98(11):1997-2000. PubMed ID: 7436834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneo-viscero-hemolytic loxoscelism with acute renal failure].
    Alfaro FV; Dotto B; Sesin AM; Prettini V; Sesin J; Aliciardi E; Vergottini JC; Gonzalez M
    Rev Fac Cien Med Univ Nac Cordoba; 2008; 65(4):142-6. PubMed ID: 20803945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
    Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
    Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare cause of secondary hemophagocytic lymphohistiocytosis: systemic loxoscelism.
    Erat T; Yahşi A; Çanakçı C; Korkmaz A; Karahan C; İleri T; Serel S; Atilla H; Kundakçı N; Özdemir H; İnce E; Çiftçi E
    Turk J Pediatr; 2020; 62(4):641-646. PubMed ID: 32779417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
    de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viscerocutaneous loxoscelism: case report and update on management].
    Harz-Fresno I; Manterola P; Ru Z M; Abud C
    Rev Chilena Infectol; 2015 Apr; 32(2):230-3. PubMed ID: 26065458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.